Dr. Batlevi on Challenges Faced in Follicular Lymphoma Management

Video

In Partnership With:

Connie L. Batlevi, MD, PhD, discusses challenges faced in the treatment of patients with follicular lymphoma.

Connie L. Batlevi, MD, PhD, a medical oncologist specializing in lymphoma at Memorial Sloan Kettering Cancer Center, discusses challenges faced in the treatment of patients with follicular lymphoma.

The lifetime of a patient with follicular lymphoma spans several decades, during which they may require intermittent treatment, says Batlevi. One of the challenges with this disease is determining which treatment can extend disease-free interval for the longest period of time while allowing patients to remain functional; this should be an individualized decision made with the patient, says Batlevi.

Other times, as a patient matures, they acquire different comorbidities and other health issues that are more prominent. In these instances, a physician might have to consider how to manage the disease at the same time as other medical conditions, some of which can be more significant than the follicular lymphoma itself, concludes Batlevi.

Related Videos
Scott Kopetz, MD, PhD, FACP
Katharina Hoebel, MD, PhD
Catherine C. Coombs, MD, associate clinical professor, medicine, University of California, Irvine School of Medicine
Naomi Adjei, MD, MPH, MSEd, gynecologic oncology fellow, The University of Texas MD Anderson Cancer Center
John M. Kirkwood, MD, Distinguished Service Professor of Medicine, Sandra and Thomas Usher Professor of Medicine, Dermatology & Translational Science, coleader, Melanoma and Skin Cancer Program, Division of Hematology/Oncology, the University of Pittsburgh
Nizar M. Tannir, MD, FACP, professor; Ransom Horne, Jr. Professor for Cancer Research, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center
William B. Pearse, MD
Daniel Olson, MD
Nan Chen, MD
Robert Dreicer, MD, director, Solid Tumor Oncology, Division of Hematology/Oncology, professor of Medicine and Urology, deputy director, University of Virginia Cancer Center